Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3D printed pharmaceutical company, have announced a partnership to advance 3D printed nanomedicines. Both the companies are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3D printed dosage forms.
This collaboration seeks to provide customers and the pharmaceutical industry with new capabilities in patient centric therapies by developing 3D printed nanomedicines.
3D Printed Nanomedicines
The immediate product innovation target for the collaboration is to combine Nanoform’s fast dissolution nanoformed particles with Aprecia’s ZipDose(TM) technology platform for rapid disintegration to enable high performance buccal and oral delivery of medicines to patients where rapid absorption is essential. Additional benefits may include lower dosage products, less excipient content, and reduced pill burden.
Prof. Edward Hæggström, CEO of Nanoform, explained, “Small is Powerful – and now in ZipDose! At the heart of everything we do is the patient. This is a fantastic opportunity to demonstrate the power of small for rapid drug absorption, potentially bypassing the first-pass metabolism via a novel dosage form such as buccal delivery with Aprecia’s 3D printing technology platforms. We look forward to this exciting collaboration (to advance 3D printed nanomedicines) and to supporting our pharmaceutical partners with this unique offering for fast acting and quick dissolving nanomedicines.”
Chris Gilmore, CEO of Aprecia said, “Aprecia’s proprietary 3D printing technology platforms, are focused on providing solutions to our partner’s toughest formulation challenges that can’t be achieved through conventional manufacturing technologies. The opportunity to join forces with Nanoform will enable new fast acting and high performance buccal and oral dosage forms not previously seen in the industry. With the first and only FDA approval for a product utilizing these leading edge 3D printing technology platforms, along with the world’s only commercial scale equipment and manufacturing process, Aprecia is paving the way for our current partners and future customers to make the medication experience better for both the patient and the caregiver.”
About Nanoform: Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies.
About Aprecia: Founded in 2003, Aprecia received the first and only FDA-approved 3D printed pharmaceutical product approval in 2015 and is the global leader in utilizing 3D printing technology for commercial-scale, pharmaceutical manufacturing.
About Manufactur3D Magazine: Manufactur3D is an online magazine on 3D Printing. Visit our Global News page for more updates on Global 3D Printing News. To stay up-to-date about the latest happenings in the 3D printing world, like us on Facebook or follow us on LinkedIn and Twitter.